Short Interest Ticks Up in Large-Cap Biotech, Specifically Amgen (AMGN)
Tweet Send to a Friend
Get Alerts AMGN Hot Sheet
Price: $101.50 +2.44%
Rating Summary:
12 Buy, 15 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 12 | New: 30
Rating Summary:
12 Buy, 15 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 12 | New: 30
Trade AMGN Now!
Analysts at Jefferies commented on short interest in the biotech space. The firm noted that as of as of December 27, 2011, weighted average short interest levels increased +0.5% for large-cap biotech stocks, fell 0.7% for mid-caps, remained relatively flat for smid-caps, and decreased -0.2% for small-cap and micro-caps.
In the large-cap biotech space, the ratio for Amgen (Nasdaq: AMGN) increased 1.9%. The increase in AMGN skewed the overall ratio. The remaining 4 large caps showed slight decreases in the ratio.
In mid-cap, United Therapeutics Corporation (NASDAQ: UTHR) and Onyx Pharmaceuticals (Nasdaq: ONXX) had the most significant decreases at t -3.5% and -1.2%, respectively. Regeneron Pharmaceuticals (Nasdaq: REGN) and Cubist Pharmaceuticals (Nasdaq: CBST) had the biggest increases at +0.3% and +0.1%, respectively.
In smid-caps, the most significant decreases in the ratio include NPS Pharmaceuticals (Nasdaq: NSPS) and Acorda Therapeutics (Nasdaq: ACOR) at -1.7% and -1.3, respectively. The most notable increases were in Dendreon (Nasdaq: DNDN) and Spectrum Pharmaceuticals (Nasdaq: SPPI) I at +2.0% and +1.6%, respectively.
In Small-caps, the most significant decreases in the ratio include Enzon Pharmaceuticals (Nasdaq: ENZN) and AMAG Pharmaceuticals (Nasdaq: AMAG) at -1.5% and -1.2%, respectively. The most notable increases were in Oncothyreon (Nasdaq: ONTY) and Synageva BioPharma (Nasdaq: GEVA) at +2.5% and +1.3%, respectively.
In Micro Caps, companies with the most significant decreases in the ratio include Metabolix (Nasdaq: MBLX) and GTx, Inc. (Nasdaq: GTXI) at -2.4% and -0.7%, respectively. y. Companies with notable increases in the ratio include Affymax (Nasdaq: AFFY) and Targacept (Nasdaq: TRGT) at +2.3% and +0.9%, respectively.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
In the large-cap biotech space, the ratio for Amgen (Nasdaq: AMGN) increased 1.9%. The increase in AMGN skewed the overall ratio. The remaining 4 large caps showed slight decreases in the ratio.
In mid-cap, United Therapeutics Corporation (NASDAQ: UTHR) and Onyx Pharmaceuticals (Nasdaq: ONXX) had the most significant decreases at t -3.5% and -1.2%, respectively. Regeneron Pharmaceuticals (Nasdaq: REGN) and Cubist Pharmaceuticals (Nasdaq: CBST) had the biggest increases at +0.3% and +0.1%, respectively.
In smid-caps, the most significant decreases in the ratio include NPS Pharmaceuticals (Nasdaq: NSPS) and Acorda Therapeutics (Nasdaq: ACOR) at -1.7% and -1.3, respectively. The most notable increases were in Dendreon (Nasdaq: DNDN) and Spectrum Pharmaceuticals (Nasdaq: SPPI) I at +2.0% and +1.6%, respectively.
In Small-caps, the most significant decreases in the ratio include Enzon Pharmaceuticals (Nasdaq: ENZN) and AMAG Pharmaceuticals (Nasdaq: AMAG) at -1.5% and -1.2%, respectively. The most notable increases were in Oncothyreon (Nasdaq: ONTY) and Synageva BioPharma (Nasdaq: GEVA) at +2.5% and +1.3%, respectively.
In Micro Caps, companies with the most significant decreases in the ratio include Metabolix (Nasdaq: MBLX) and GTx, Inc. (Nasdaq: GTXI) at -2.4% and -0.7%, respectively. y. Companies with notable increases in the ratio include Affymax (Nasdaq: AFFY) and Targacept (Nasdaq: TRGT) at +2.3% and +0.9%, respectively.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Morgan Stanley Maintains Bullish Stance on Walter Energy (WLT)
- UPDATE: Canaccord Genuity Starts T-Mobile US, (TMUS) at Hold
- Wells Fargo Starts StealthGas (GASS) at Outperform
Create E-mail Alert Related Categories
Analyst Comments, Trader TalkRelated Entities
Jefferies & Co
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
